{"content":"<li class=\"n-box-item date-title\" data-end=\"1482987599\" data-start=\"1482901200\" data-txt=\"Sunday, December 22, 2019\">Wednesday, December 28, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3232733\" data-ts=\"1482971599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGCP\" target=\"_blank\">BGCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232733-bgc-partners-updates-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BGC Partners updates Q4 guidance</a></h4><ul>   <li>Brokerage company BGC Partners (<a href=\"https://seekingalpha.com/symbol/BGCP\" title=\"BGC Partners, Inc.\">BGCP</a> <font color=\"red\">-2.1%</font>) issued an <a href=\"https://www.sec.gov/Archives/edgar/data/1094831/000119312516805732/d284251d8k.htm\" target=\"_blank\">update to its outlook</a> for the fourth quarter.</li>    <li>The company now sees revenues around the midpoint of previous guidance, and for pretax distributable earnings to sit in the high end of its range.</li>    <li>With <a href=\"http://www.bgcpartners.com/wp-content/uploads/2016/10/3Q2016-Release-final-FINAL-21.pdf\" target=\"_blank\">third-quarter earnings</a>, the company had guided to Q4 revenues of $630M-$675M, and for pretax distributable earnings to increase between 3 and 21% (in the range of $107M-$125M).</li>    <li>BGC will issue a release regarding the availability of its results by 8 a.m. ET Feb. 9.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232733\" data-linked=\"BGC Partners updates Q4 guidance\" data-tweet=\"$BGCP - BGC Partners updates Q4 guidance https://seekingalpha.com/news/3232733-bgc-partners-updates-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3232733-bgc-partners-updates-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232729\" data-ts=\"1482968477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232729-new-residential-inks-msr-purchase-deal-phh-corp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Residential inks MSR purchase deal with PHH Corp.</a></h4><ul>\n<li>New Residential (NYSE:<a href=\"https://seekingalpha.com/symbol/NRZ\" title=\"New Residential Investment Corp.\">NRZ</a>) agrees to buy about $72B UPB of seasoned agency and private-label MBS from PHH Corp. (NYSE:<a href=\"https://seekingalpha.com/symbol/PHH\" title=\"PHH Corporation\">PHH</a>) for roughly $612M. Alongside, NRZ will buy about $300M of servicer advances from PHH.</li>\n<li>Also part of the deal, PHH will subservice the mortgages (480K of them) underlying the purchased MSRs for an initial period of three years.</li>\n<li>The deal is expected to close in H1.</li>\n<li>For PHH's part, it sold the MSRs for about 84 basis points of the UPB, and the $912M in proceeds will be used to pay down debt. The deal rids PHH of its remaining MSR portfolio. The company continues to study strategic options, and expects to have something to present to investors by the end of January.</li>\n<li>NRZ <font color=\"green\">+0.4%</font>, PHH <font color=\"green\">+1.5%</font> after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232729\" data-linked=\"New Residential inks MSR purchase deal with PHH Corp.\" data-tweet=\"$NRZ $NRZ $PHH - New Residential inks MSR purchase deal with PHH Corp. https://seekingalpha.com/news/3232729-new-residential-inks-msr-purchase-deal-phh-corp?source=tweet\" data-url=\"https://seekingalpha.com/news/3232729-new-residential-inks-msr-purchase-deal-phh-corp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232722\" data-ts=\"1482964509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232722-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/XENT' title='Intersect ENT'>XENT</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='green'>+1.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/NVGS' title='Navigator Holdings Ltd.'>NVGS</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/PJT' title='PJT Partners Inc.'>PJT</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='red'>-1.6%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='red'>-1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232722\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MT $MYL $CNAT - After Hours Gainers / Losers https://seekingalpha.com/news/3232722-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232722-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232719\" data-ts=\"1482963869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232719-fortress-biotechplus-32-after-hours-mbminus-101-case-study-forthcoming-complete-remission-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortress Biotech +32% after hours; MB-101 case study forthcoming, complete remission in patient with recurrent glioblastoma cited</a></h4><ul>\n<li>Case study from phase 1 clinical trial of MB-101 (IL13Rα2-specific, Chimeric Antigen Receptor engineered CAR T cells [CAR T cells]) for the treatment of glioblastoma [GBM] to be distributed in December 29 edition of the <em>New England Journal of Medicine</em>.</li>\n<li>\n<a href=\"http://www.mustangbio.com/pipeline/mb-101/\" target=\"_blank\">MB-101</a> is a lead development candidate of Fortress Biotech (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FBIO\" title=\"Fortress Biotech, Inc.\">FBIO</a>) company, Mustang Bio.</li>\n<li>Shares to $3.03 after closing out at $2.29.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232719\" data-linked=\"Fortress Biotech +32% after hours; MB-101 case study forthcoming, complete remission in patient with recurrent glioblastoma cited\" data-tweet=\"$FBIO $MBIO - Fortress Biotech +32% after hours; MB-101 case study forthcoming, complete remission in patient with recurrent glioblastoma cited https://seekingalpha.com/news/3232719-fortress-biotechplus-32-after-hours-mbminus-101-case-study-forthcoming-complete-remission-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3232719-fortress-biotechplus-32-after-hours-mbminus-101-case-study-forthcoming-complete-remission-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232685\" data-ts=\"1482955250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232685-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> MSDI <font color=\"green\">+96%</font>. DRAM <font color=\"green\">+44%</font>. <a href=\"https://seekingalpha.com/symbol/CNTF\" title=\"China TechFaith Wireless Communication Technology Limited\">CNTF</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/IPDN\" title=\"Professional Diversity Network\">IPDN</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/FNJN\" title=\"Finjan Holdings, Inc.\">FNJN</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/PI\" title=\"Impinj, Inc.\">PI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/SOFO\" title=\"Sonic Foundry, Inc.\">OTC:SOFO</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/XGTI\" title=\"xG Technology, Inc.\">XGTI</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/MTSL\" title=\"MER Telemanagement Solutions Ltd.\">MTSL</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232685\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$INNT $USAU $CNTF - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3232685-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232685-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232683\" data-ts=\"1482954473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXD\" target=\"_blank\">PXD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232683-loosening-credit-shale-drillers-set-to-expand-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loosening credit has shale drillers set to expand investment</a></h4><ul>   <li>Shale drillers are set to increase budgets next year, with a <a href=\"http://www.reuters.com/article/us-oil-energy-banking-idUSKBN14H1GP\" target=\"_blank\">little help from their banks</a>.</li>    <li>An oil price recovery is prompting lenders to extend credit lines for the first time in two years. And even a small increase (Reuters estimates an average of 5%) has a number of producers including Pioneer Natural Resources (<a href=\"https://seekingalpha.com/symbol/PXD\" title=\"Pioneer Natural Resources Company\">PXD</a> <font color=\"red\">-1.8%</font>), Diamondback Energy (<a href=\"https://seekingalpha.com/symbol/FANG\" title=\"Diamondback Energy\">FANG</a> <font color=\"red\">-0.9%</font>) and RSP Permian (<a href=\"https://seekingalpha.com/symbol/RSPP\" title=\"RSP Permian\">RSPP</a> <font color=\"red\">-1.3%</font>) boosting expenditure forecasts for the coming year.</li>    <li>Raymond James expects oil and gas producers with a North American focus to increase capital investment by 30% in 2017.</li>    <li>\"The 'animal spirits' seem to be coming back to the exploration and production market, albeit slowly,\" said analyst Kyle Owusu after the past three industry reviews saw available credit cut by 40%.</li>    <li>While some companies are seeing big expansions in their borrowing base -- Rice Energy's (<a href=\"https://seekingalpha.com/symbol/RICE\" title=\"Rice Energy Inc\">RICE</a> <font color=\"red\">-0.6%</font>) was boosted to $1.45B from $1B after it bought Vantage Energy -- others go a different route (Carrizo (<a href=\"https://seekingalpha.com/symbol/CRZO\" title=\"Carrizo Oil &amp; Gas, Inc.\">CRZO</a> <font color=\"red\">-3.1%</font>) has kept its credit line steady at $600M and sold $225M in stock to fund land buys).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232683\" data-linked=\"Loosening credit has shale drillers set to expand investment\" data-tweet=\"$PXD $PXD $FANG - Loosening credit has shale drillers set to expand investment https://seekingalpha.com/news/3232683-loosening-credit-shale-drillers-set-to-expand-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3232683-loosening-credit-shale-drillers-set-to-expand-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232677\" data-ts=\"1482953043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232677-michael-kors-coach-rise-intraday-amid-reports-kate-spade-exploring-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors, Coach rise intraday amid reports Kate Spade exploring sale</a></h4><ul>\n<li>Since just prior to an <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">initial volatility halt</a> placed on Kate Spade trade at 12:33 PM ET, Michael Kors (KORS) and Coach (COH) are both <font color=\"green\">up roughly 2.6%</font> to respective $43.24 and $35.09 levels.</li>\n<li>Investors are responding actively across the names on reports Kate Spade is exploring a sale, with that company's shares now at <font color=\"green\">nearly 25% gains</font> on the session.</li>\n<li>Earlier: <a href=\"https://seekingalpha.com/news/3232656-kate-spade-plus-15_85-percent-sale-exploration-reported-updated\" target=\"_blank\">Kate Spade +15.85%, sale exploration reported [updated]</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232677\" data-linked=\"Michael Kors, Coach rise intraday amid reports Kate Spade exploring sale\" data-tweet=\"$CPRI $CPRI $TPR - Michael Kors, Coach rise intraday amid reports Kate Spade exploring sale https://seekingalpha.com/news/3232677-michael-kors-coach-rise-intraday-amid-reports-kate-spade-exploring-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3232677-michael-kors-coach-rise-intraday-amid-reports-kate-spade-exploring-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232671\" data-ts=\"1482951890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232671-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corporation'>AXU</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+5%</font>. MPET <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/CHNR' title='China Natural Resources, Inc.'>CHNR</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BIOA' title='BioAmber'>OTC:BIOA</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3232671\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$AXU $KLDX $TELL - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3232671-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232671-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232670\" data-ts=\"1482951878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KYO-OLD\" target=\"_blank\">KYO-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232670-avxminus-4_15-kyocera-notifies-of-intent-to-market-products-independently\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVX -4.15%, Kyocera notifies of intent to market products independently</a></h4><ul>\n<li>Effective January 1, 2018, Kyocera (NYSE:<a href=\"https://seekingalpha.com/symbol/KYO-OLD\" title=\"Kyocera Corporation\">KYO-OLD</a>), holder of 72% of AVX's (NYSE:<a href=\"https://seekingalpha.com/symbol/AVX\" title=\"AVX Corp.\">AVX</a>) outstanding shares, plans to market manufactured products worldwide using its own sales force instead of through AVX reselling in the Americas, Europe and Asia.</li>\n<li>Kyocera resale products are recorded at $261.8M in revenue and $16.7M in related operating profit for the FY 2016 term ended March 31, 2016.</li>\n<li><a href=\"https://seekingalpha.com/filing/3336845\" target=\"_blank\">8-K</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232670\" data-linked=\"AVX -4.15%, Kyocera notifies of intent to market products independently\" data-tweet=\"$KYO-OLD $KYO-OLD $AVX - AVX -4.15%, Kyocera notifies of intent to market products independently https://seekingalpha.com/news/3232670-avxminus-4_15-kyocera-notifies-of-intent-to-market-products-independently?source=tweet\" data-url=\"https://seekingalpha.com/news/3232670-avxminus-4_15-kyocera-notifies-of-intent-to-market-products-independently\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232657\" data-ts=\"1482947345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232657-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> DRAM <font color='green'>+45%</font>. GALE <font color='green'>+40%</font>. MSDI <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/MICT' title='Micronet Enertec Technologies, Inc.'>MICT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='green'>+19%</font>. SGNL <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-65%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VISN' title='VisionChina Media, Inc.'>VISN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232657\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$USAU $SLS $INNT - Midday Gainers / Losers https://seekingalpha.com/news/3232657-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232657-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232656\" data-ts=\"1482946928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KATE\" target=\"_blank\">KATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232656-kate-spadeplus-15_85-sale-exploration-reported-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kate Spade +15.85%, sale exploration reported [updated]</a></h4><ul>\n<li>\n<a href=\"http://www.cnbc.com/2016/12/28/kate-spade-shares-jump-on-report-that-company-may-be-exploring-a-sale.html\" target=\"_blank\">Developing</a>.</li>\n<li>Shares (NYSE:<a href=\"https://seekingalpha.com/symbol/KATE\" title=\"Kate Spade &amp; Company\">KATE</a>) <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">had been halted</a> for volatility and subsequently resumed as of 12:39 PM ET.</li>\n<li>\n<strong>Update (12:50 PM ET)</strong>: Trading halt reinstated at 12:42 PM ET, also on volatility, and again resumed at 12:48PM ET with shares active <font color=\"green\">18%+</font> higher.</li>\n<li>\n<strong>Update (1:00 PM ET)</strong>: <a href=\"http://www.wsj.com/articles/kate-spade-co-explores-sale-1482947046\" target=\"_blank\">Reportedly</a> under pressure from activist shareholder Caerus Investors, early stage work with a bank and contact with prospective buyers, inclusive of other retailers, is suggested.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232656\" data-linked=\"Kate Spade +15.85%, sale exploration reported [updated]\" data-tweet=\"$KATE - Kate Spade +15.85%, sale exploration reported [updated] https://seekingalpha.com/news/3232656-kate-spadeplus-15_85-sale-exploration-reported-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3232656-kate-spadeplus-15_85-sale-exploration-reported-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232654\" data-ts=\"1482944760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232654-intercept-pharmaceuticalsplus-6_86-speculation-involving-novartis-interest-circulating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharmaceuticals +6.86%; speculation involving Novartis interest circulating</a></h4><ul><li><a href=\"http://www.streetinsider.com/Hot+M+and+A/Intercept+Pharma+%28ICPT%29+Gains+as+Novartis+%28NVS%29+Said+Interested+in+Bid/12375143.html\" target=\"_blank\">Details limited</a>.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) to $111.02, Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>)&nbsp;<font color='red'>-0.29%</font>&nbsp;at $71.83.</li></ul><div class=\"tiny-share-widget\" data-id=\"3232654\" data-linked=\"Intercept Pharmaceuticals +6.86%; speculation involving Novartis interest circulating\" data-tweet=\"$ICPT $ICPT $NVS - Intercept Pharmaceuticals +6.86%; speculation involving Novartis interest circulating https://seekingalpha.com/news/3232654-intercept-pharmaceuticalsplus-6_86-speculation-involving-novartis-interest-circulating?source=tweet\" data-url=\"https://seekingalpha.com/news/3232654-intercept-pharmaceuticalsplus-6_86-speculation-involving-novartis-interest-circulating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232652\" data-ts=\"1482944414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232652-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods'>ANFI</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232652\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FFHL $DFBG-OLD $ANFI - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3232652-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232652-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232651\" data-ts=\"1482943284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCRX\" target=\"_blank\">OCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232651-h-c-wainwright-co-starts-ocera-therapeutics-buy-10-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H.C. Wainwright &amp; Co. starts Ocera Therapeutics at Buy, $10 target</a></h4><ul>\n<li>\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8845495/ocera-therapeutics-shares-could-rally-to-10\" target=\"_blank\">Analyst Ed Arce</a> highlights Ocera Therapeutics lead drug <a href=\"http://www.ocerainc.com/ocr-002/\" target=\"_blank\">OCR-002</a>, suggesting its \"potential to become the gold standard\" among hepatic encephalopathy therapies.</li>\n<li>Shares in Ocera Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OCRX\" title=\"Ocera Therapeutics, Inc.\">OCRX</a>) are currently priced at a $2.60 level, <font color=\"green\">higher by 18.18</font>% nearing midday.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232651\" data-linked=\"H.C. Wainwright &amp; Co. starts Ocera Therapeutics at Buy, $10 target\" data-tweet=\"$OCRX - H.C. Wainwright &amp; Co. starts Ocera Therapeutics at Buy, $10 target https://seekingalpha.com/news/3232651-h-c-wainwright-co-starts-ocera-therapeutics-buy-10-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3232651-h-c-wainwright-co-starts-ocera-therapeutics-buy-10-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232648\" data-ts=\"1482940826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232648-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> GALE <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-66%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PTX' title='Pernix Therapeutics Holdings, Inc.'>PTX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232648\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$SLS $OCRX $CYCC - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3232648-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3232648-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232645\" data-ts=\"1482939491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BK\" target=\"_blank\">BK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232645-bank-of-new-york-mellon-upgraded-to-strong-buy-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of New York Mellon upgraded to Strong Buy at Raymond James</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Raymond+James+Upgrades+Bank+of+New+York+Mellon+%28BK%29+to+Strong+Buy/12374427.html\" target=\"_blank\">Analyst David Long</a> moves a level up from Outperform and raises target from $50 to $57, citing recent underperformance, overblown prospective market headwinds and what he believes to be an appealing entry point.</li>\n<li>Further sees benefits from steeper yield curve, recent federal funds rate hike, heightened volume and volatility within capital markets (FX trading, securities lending), higher equity market valuations and positive long-term indicators among worldwide custody/servicing segment.</li>\n<li>Bank of New York Mellon (NYSE:<a href=\"https://seekingalpha.com/symbol/BK\" title=\"The Bank of New York Mellon Corporation\">BK</a>) <font color=\"green\">+1.11%</font> to $48.26.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232645\" data-linked=\"Bank of New York Mellon upgraded to Strong Buy at Raymond James\" data-tweet=\"$BK - Bank of New York Mellon upgraded to Strong Buy at Raymond James https://seekingalpha.com/news/3232645-bank-of-new-york-mellon-upgraded-to-strong-buy-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3232645-bank-of-new-york-mellon-upgraded-to-strong-buy-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232644\" data-ts=\"1482937656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232644-citron-research-cautious-on-nvidia-projects-return-to-90\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron Research cautious on Nvidia, projects return to $90</a></h4><ul>\n<li>Suggesting <a href=\"https://twitter.com/CitronResearch/status/814118491607285760\" target=\"_blank\">market disregard for headwinds</a>, Citron Research notes Nvidia growth primarily stemming from gaming at the expense of Advanced Micro Devices, and not through new total addressable markets, presence of major data center competition from legacy and newcomer players [Intel Xeon Phi, AMD Radeon Pro and new desktop and server GPUs to come in 2017, Xilinx], access of Nvidia intellectual property Intel already maintains through a licensing deal set to end this year, impact attrition of Intel licensing revenue will have on 2017 EBITDA, impact increasing Intel competition will have on gross margins and competition from existing customers [Google's TPU, Apple].</li>\n<li>Nvidia (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a>) <font color=\"red\">-2.94%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232644\" data-linked=\"Citron Research cautious on Nvidia, projects return to $90\" data-tweet=\"$NVDA - Citron Research cautious on Nvidia, projects return to $90 https://seekingalpha.com/news/3232644-citron-research-cautious-on-nvidia-projects-return-to-90?source=tweet\" data-url=\"https://seekingalpha.com/news/3232644-citron-research-cautious-on-nvidia-projects-return-to-90\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232638\" data-ts=\"1482935289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232638-live-venturesplus-29-after-wrapping-record-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Ventures +29% after wrapping record year</a></h4><ul>   <li>Live Ventures (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LIVE\" title=\"Live Ventures\">LIVE</a>) is <font color=\"green\">up 29.6%</font> premarket after posting record earnings and wrapping what it said was the most successful year in its history.</li>    <li>It noted a record $79M in revenues for the year (up 136%) and net profit of about $17.82M -- about $8.92 per share.</li>    <li>That's largely attributable to net operating losses it built up before becoming a diversified holding company.</li>    <li>Stockholders' equity rose 192% Y/Y, the company says, and present management points to its CAGR on that measure of 100.58% since it took over five years ago.</li>    <li>In 2017 guidance, the company expects \"multiple\" factors to have an impact. Revenues should increase by \"well over 50%, easily surpassing $120M,\" and stockholders' equity to grow in high double digits.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232638\" data-linked=\"Live Ventures +29% after wrapping record year\" data-tweet=\"$LIVE - Live Ventures +29% after wrapping record year https://seekingalpha.com/news/3232638-live-venturesplus-29-after-wrapping-record-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3232638-live-venturesplus-29-after-wrapping-record-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232636\" data-ts=\"1482934705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCEI\" target=\"_blank\">BCEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232636-bonanza-creek-energy-resumes-decline-after-bankruptcy-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bonanza Creek Energy resumes decline after bankruptcy news</a></h4><ul>   <li>After a relief move up yesterday, Bonanza Creek Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a>) -- which tumbled 58% Friday on news it would file for bankruptcy -- is <font color=\"red\">off another 19%</font> premarket today.</li>    <li>The Denver-based company said it planned to eliminate $850M in debt and provide $200M in new equity with a Chapter 11 restructuring. It expects to file by Jan. 5 and exit bankruptcy protection in the first quarter.</li>    <li>Bankruptcy filings for oil and gas producers more than doubled this year vs. last year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232636\" data-linked=\"Bonanza Creek Energy resumes decline after bankruptcy news\" data-tweet=\"$BCEI - Bonanza Creek Energy resumes decline after bankruptcy news https://seekingalpha.com/news/3232636-bonanza-creek-energy-resumes-decline-after-bankruptcy-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3232636-bonanza-creek-energy-resumes-decline-after-bankruptcy-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232635\" data-ts=\"1482934615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232635-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> GALE <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/MICT' title='Micronet Enertec Technologies, Inc.'>MICT</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3232635\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$SLS $LIVE $MICT - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3232635-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3232635-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232633\" data-ts=\"1482933829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232633-galena-biopharmaplus-25-blood-cancer-therapy-advances\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena Biopharma +25% as blood cancer therapy advances</a></h4><ul>   <li>Galena Biopharma (GALE) is <font color=\"green\">up 25%</font> premarket after confirming a regulatory pathway for a new drug application for its GALE-401 blood cancer therapy.</li>    <li>After a \"productive\" meeting with the FDA, the company believes a pivotal phase 3 trial is appropriate to move GALE-401 (Anagrelide controlled release) through the 505(b)(2) path.</li>    <li>The company expects to initiate the trial, which will enroll patients with essential thrombocythemia who have either failed or are intolerant to hydroxyurea, in the second quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232633\" data-linked=\"Galena Biopharma +25% as blood cancer therapy advances\" data-tweet=\"$SLS - Galena Biopharma +25% as blood cancer therapy advances https://seekingalpha.com/news/3232633-galena-biopharmaplus-25-blood-cancer-therapy-advances?source=tweet\" data-url=\"https://seekingalpha.com/news/3232633-galena-biopharmaplus-25-blood-cancer-therapy-advances\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232629\" data-ts=\"1482931418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLBL\" target=\"_blank\">GLBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232629-knighthead-takes-stake-in-terraform-global\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knighthead takes stake in Terraform Global</a></h4><ul><li>Terraform Global (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBL' title='TerraForm Global'>GLBL</a>) <font color='green'>rose 2.5%</font> in extended trading on Tuesday after Knighthead Capital <a href=\"http://www.streetinsider.com/13Ds/Knighthead+Capital+Management,+LLC+Raises+Stake+in+Global+Industries+Ltd+to+6.43%25+-+13D/12373934.html\" target=\"_blank\">disclosed</a> a 6.4% stake in the alternative energy company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3232629\" data-linked=\"Knighthead takes stake in Terraform Global\" data-tweet=\"$GLBL - Knighthead takes stake in Terraform Global https://seekingalpha.com/news/3232629-knighthead-takes-stake-in-terraform-global?source=tweet\" data-url=\"https://seekingalpha.com/news/3232629-knighthead-takes-stake-in-terraform-global\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232608\" data-ts=\"1482909328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSYY\" target=\"_blank\">TOSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232608-toshiba-shares-down-20-hit-daily-limit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba shares down 20%, hit daily limit</a></h4><ul>\n<li>Toshiba (<a href=\"https://seekingalpha.com/symbol/TOSYY\" title=\"Toshiba Corp. ADR\">OTCPK:TOSYY</a>) shares <font color=\"red\">tumbled 20%</font> overnight, hitting the Tokyo exchange's daily downward limit, after the company said it could <a href=\"http://www.cnbc.com/2016/12/27/toshiba-flags-hit-of-billions-of-dollars-on-us-nuclear-acquisition.html\" target=\"_blank\">face</a> a multi-billion dollar charge on the nuclear power unit it acquired last year from CB&amp;I (NYSE:<a href=\"https://seekingalpha.com/symbol/CBI\" title=\"Chicago Bridge &amp; Iron Company\">CBI</a>).</li>\n<li>Addressing reporters late on Tuesday, Toshiba executives declined to provide further details about the writedown, adding that the sum would be finalized by mid-February.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232608\" data-linked=\"Toshiba shares down 20%, hit daily limit\" data-tweet=\"$TOSYY $TOSYY $CBI - Toshiba shares down 20%, hit daily limit https://seekingalpha.com/news/3232608-toshiba-shares-down-20-hit-daily-limit?source=tweet\" data-url=\"https://seekingalpha.com/news/3232608-toshiba-shares-down-20-hit-daily-limit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":23,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}